SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-013089
Filing Date
2020-05-14
Accepted
2020-05-14 16:31:06
Documents
1
Period of Report
2020-05-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 10812
  Complete submission text file 0000899243-20-013089.txt   12405
Mailing Address 34 YERUSHALAYIM RD. RAANANA L3 4350110
Business Address 34 YERUSHALAYIM RD. RAANANA L3 4350110 972(73)3989560
aMoon 2 Fund Limited Partnership (Reporting) CIK: 0001744099 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39279 | Film No.: 20878280

Mailing Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801
Business Address 1313 N. MARKET STREET SUITE 5100 WILMINGTON DE 19801 (857) 444-0553
Ayala Pharmaceuticals, Inc. (Issuer) CIK: 0001797336 (see all company filings)

IRS No.: 823578375 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)